What is the recommended treatment for a patient with chronic iron-deficiency anemia and copper-dependent anemia, with laboratory findings indicating severe iron deficiency, copper deficiency, and borderline vitamin A status, while on testosterone replacement therapy (TRT) and regular therapeutic phlebotomy?

Treatment of Chronic Iron-Deficiency and Copper-Dependent Anemia in a Patient on TRT with Regular Phlebotomy

Copper supplementation must be initiated first at 2 mg daily before starting iron therapy, because copper deficiency blocks iron mobilization and prevents iron from reaching the bone marrow—treating iron deficiency alone will fail until copper is repleted. 1, 2

Immediate Management Priority: Copper Repletion

Begin with oral copper supplementation 2 mg daily (copper bisglycinate or copper gluconate) taken with food. 1 Copper deficiency causes a functional iron-deficiency anemia that is refractory to iron therapy because ceruloplasmin (a copper-dependent enzyme) is required to oxidize ferrous iron so transferrin can transport it to the bone marrow. 2 Your patient's ceruloplasmin of 15.8 mg/dL (reference 16.0–31.0) and serum copper of 61 µg/dL (reference 69–132) confirm this deficiency. 2

• Hematologic improvement typically occurs within 4–6 weeks of copper supplementation, with reticulocyte count rising first, followed by correction of anemia and neutropenia. 1, 2
• Neurological manifestations of copper deficiency (myelopathy, ataxia, paresthesias) may be irreversible if treatment is delayed, making early copper repletion critical. 3, 4
• Do not exceed 10 mg copper daily; toxicity can occur at higher doses. 1

Critical Pitfall: Zinc-Copper Antagonism

Avoid high-dose zinc supplementation (>25 mg daily) because zinc competitively inhibits copper absorption and can precipitate or worsen copper deficiency. 1, 2 If zinc is medically necessary, maintain a zinc:copper ratio of approximately 10:1 (e.g., 25 mg zinc with 2.5 mg copper). 2

---

Iron Supplementation: Start After One Week of Copper Therapy

After initiating copper for 7 days, begin oral iron supplementation with ferrous bisglycinate 25 mg elemental iron daily, taken on an empty stomach or with a small amount of food. 1, 5 Ferrous bisglycinate is better tolerated than ferrous sulfate and causes fewer gastrointestinal side effects. 1

• Co-administer 250–500 mg vitamin C (ascorbic acid) with each iron dose to enhance non-heme iron absorption. 1, 5
• Avoid taking iron within 2 hours of calcium, dairy products, caffeine, or high-zinc supplements, which impair iron absorption. 1, 6
• In patients with active inflammation (elevated CRP), oral iron absorption is compromised; if ferritin does not rise after 6–8 weeks despite adherence, switch to intravenous iron therapy. 1

Monitoring Iron Response

• Expect hemoglobin to rise by approximately 2 g/dL after 3–4 weeks of combined copper and iron therapy. 5
• Recheck CBC, ferritin, serum iron, TIBC, transferrin saturation, and sTfR at 6–8 weeks. 1, 5 Watch for rising MCV/MCH (red cells becoming larger and more hemoglobin-rich) and increasing ferritin. 1
• Continue iron therapy for 3 months after hemoglobin normalizes to replenish iron stores (target ferritin 50–100 ng/mL). 5

---

Adjunctive Micronutrient Support

Vitamin A (Retinol)

Supplement with 900 µg retinol activity equivalents (RAE) daily (approximately 3,000 IU as retinyl palmitate or retinyl acetate). 1 Vitamin A facilitates iron mobilization from ferritin and enables copper incorporation into ceruloplasmin. 1 Your patient's borderline vitamin A level (51.9 µg/dL; reference ≥62 µg/dL) suggests deficiency. 1

• Do not exceed 3,000 µg RAE (10,000 IU) daily to avoid hypervitaminosis A toxicity. 1

Vitamin B6 (Pyridoxine)

Administer pyridoxine 50 mg orally once daily. 1 Vitamin B6 is a cofactor for δ-aminolevulinic acid synthase, the first enzyme in heme synthesis; deficiency causes microcytic anemia independent of iron status. 1

• Do not exceed 100 mg daily long-term due to risk of sensory neuropathy. 1

Vitamin C (Ascorbic Acid)

Take 250–500 mg vitamin C with each iron dose to enhance absorption. 1, 5 Higher doses offer no additional benefit and may cause gastrointestinal upset. 1

---

Addressing Testosterone-Driven Erythrocytosis and Phlebotomy

Discuss with your prescribing physician reducing testosterone dosage or lengthening the interval between injections. [@patient report] Testosterone stimulates erythropoietin and drives red-blood-cell production, which depletes iron stores when combined with regular phlebotomy. [@patient report] Your elevated RBC count (7.07 × 10⁶/µL; reference 4.14–5.80) and high-normal hematocrit (51.1%; reference 37.5–51.0) reflect testosterone-induced erythrocytosis. [@patient report]

• Avoid phlebotomy unless hematocrit exceeds 54%; unnecessary blood removal worsens iron depletion. [@patient report]
• Spacing phlebotomy sessions allows iron stores to rebuild while copper and iron supplementation take effect. [@patient report]

---

Dietary Optimization

Consume iron-rich foods (red meat, shellfish, liver, legumes) alongside vitamin C–rich vegetables and fruits to enhance absorption. 1, 5 Include copper-rich foods such as oysters, beef liver, nuts, and seeds. [@12@] Limit alcohol intake, which impairs copper absorption and utilization. [@12@]

---

Follow-Up and Long-Term Maintenance

Recheck labs at 6–8 weeks: CBC, iron panel (ferritin, serum iron, TIBC, transferrin saturation), sTfR, ceruloplasmin, serum copper, and reticulocyte count. [@3@, @4@, @6@, 5]

• Persistent anemia after 4 weeks of combined copper and iron therapy requires further evaluation for other contributing factors, such as vitamin B12 deficiency or bone marrow suppression. [1, @4@]
• Once ferritin reaches 50–100 ng/mL and copper/ceruloplasmin normalize, taper iron to 25 mg every other day and maintain copper at 1–2 mg daily. [@patient report]
• Continue vitamin A and B6 at RDA levels (900 µg RAE and 1.3–1.7 mg, respectively) for long-term maintenance. 1

---

Key Pitfalls to Avoid

• Do not start iron supplementation without first addressing copper deficiency; iron therapy will fail because copper-dependent enzymes are required for iron transport. 1, 2
• Do not use high-dose zinc supplements (>25 mg daily), which worsen copper deficiency by competitive inhibition. 1, 2
• Do not continue unnecessary phlebotomy; this perpetuates iron depletion and undermines supplementation efforts. [@patient report]
• Do not ignore neurological symptoms (ataxia, paresthesias, weakness); these may indicate copper-deficiency myelopathy, which can become irreversible if treatment is delayed. [3, @